Skin-on-a-chip model simulating inflammation, edema and drug-based treatment
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Recent advances in microfluidic cell cultures enable the construction of in vitro human skin models that can be used for drug toxicity testing, disease study. However, current in vitro skin model have limitations to emulate real human skin due to the simplicity of model. In this paper, we describe the development of ‘skin-on-a-chip’ to mimic the structures and functional responses of the human skin. The proposed model consists of 3 layers, on which epidermal, dermal and endothelial components originated from human, were cultured. The microfluidic device was designed for co-culture of human skin cells and each layer was separated by using porous membranes to allow interlayer communication. Skin inflammation and edema were induced by applying tumor necrosis factor alpha on dermal layer to demonstrate the functionality of the system. The expression levels of proinflammatory cytokines were analyzed to illustrate the feasibility. In addition, we evaluated the efficacy of therapeutic drug testing model using our skin chip. The function of skin barrier was evaluated by staining tight junctions and measuring a permeability of endothelium. Our results suggest that the skin-on-a-chip model can potentially be used for constructing in vitro skin disease models or for testing the toxicity of cosmetics or drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Soft lithography for micro- and nanoscale patterning
Qin, D., Xia, Y., & Whitesides, G. M. (2010) · Nature Protocols · doi:10.1038/nprot.2009.234 · Cited by 2,334
CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
Arai, K.-I., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004031 · Cited by 1,318
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242
Endothelial cell–cell junctions: happy together
Dejana, E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1357 · Cited by 1,188
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Living Tissue Formed in Vitro and Accepted as Skin-Equivalent Tissue of Full Thickness
Bell, E., Ehrlich, H. P., Buttle, D. J., & Nakatsuji, T. (1981) · Science · doi:10.1126/science.7008197 · Cited by 1,052
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
Tracy, L. E., Minasian, R. A., & Caterson, E. J. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0561 · Cited by 1,008
Grossman, R. M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D. P., May, L. T., Kupper, T. S., Sehgal, P. B., & Gottlieb, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6367 · Cited by 853
Research works printed but not linked: 1
- Ramadan, Q. & Ting, F. C. W. In vitro micro-physiological immune-competent model of the human skin. Lab Chip 16, 1899–1908 (2016). · DOI · Paper page
Cited by
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Advances in Hydrogels in Organoids and Organs‐on‐a‐Chip
Liu, H., Wang, Y., Cui, K., Guo, Y., Zhang, X., & Qin, J. (2019) · Advanced Materials · doi:10.1002/adma.201902042 · Cited by 353
Pattanayak, P., Singh, S. K., Gulati, M., Vishwas, S., Kapoor, B., Chellappan, D. K., Anand, K., Gupta, G., Jha, N. K., Gupta, P. K., et al. (2021) · Microfluidics and Nanofluidics · doi:10.1007/s10404-021-02502-2 · Cited by 330
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Kim, B. S., Gao, G., Kim, J. Y., & Cho, D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801019 · Cited by 289
Self-citationEvolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
Azizipour, N., Avazpour, R., Rosenzweig, D. H., Sawan, M., & Ajji, A. (2020) · Micromachines · doi:10.3390/mi11060599 · Cited by 277
Recent Advances in Body-on-a-Chip Systems
Sung, J. H., Wang, Y. I., Narasimhan Sriram, N., Jackson, M., Long, C., Hickman, J. J., & Shuler, M. L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05293 · Cited by 268
Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function
Sriram, G., Alberti, M., Dancik, Y., Wu, B., Wu, R., Feng, Z., Ramasamy, S., Bigliardi, P. L., Bigliardi-Qi, M., & Wang, Z. (2018) · Materials Today · doi:10.1016/j.mattod.2017.11.002 · Cited by 256
Tumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Organs-on-a-Chip Module: A Review from the Development and Applications Perspective
Sosa-Hernández, J. E., Villalba-Rodríguez, A. M., Romero-Castillo, K. D., Aguilar-Aguila-Isaías, M. A., García-Reyes, I. E., Hernández-Antonio, A., Ahmed, I., Sharma, A., Parra-Saldívar, R., & Iqbal, H. M. N. (2018) · Micromachines · doi:10.3390/mi9100536 · Cited by 244
“An example is a model with epidermal, dermal and endothelial layers developed to reproduce inflammation and edema treated with dexamethasone as a drug testing model [98] (similar work was presented in Reference [99]).”
MethodDomingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Microfluidics for Drug Development: From Synthesis to Evaluation
Liu, Y., Sun, L., Zhang, H., Shang, L., & Zhao, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01289 · Cited by 202
Augustine, R. (2018) · Progress in Biomaterials · doi:10.1007/s40204-018-0087-0 · Cited by 184
“Such systems can simulate inflammation, edema and test drug-based treatment (Wufuer et al. 2016).”
BackgroundDisease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells
Ho, B., Pek, N., & Soh, B.-S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040936 · Cited by 182
“This 3D-based platform allows readouts on skin permeability in the presence of fluid profusion [70].”
BackgroundReview article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Prantil-Baun, R., Novak, R., Das, D., Somayaji, M. R., Przekwas, A., & Ingber, D. E. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104748 · Cited by 176
Organs-on-chips technologies – A guide from disease models to opportunities for drug development
Monteduro, A. G., Rizzato, S., Caragnano, G., Trapani, A., Giannelli, G., & Maruccio, G. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115271 · Cited by 175
A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications
Doost, N. F., & Srivastava, S. K. (2024) · Biosensors · doi:10.3390/bios14050225 · Cited by 185
“This allows for the delivery of cell-specific media to each compartment while allowing paracrine interactions between the compartments, as demonstrated by OOC devices that mimic the skin [51] and liver [52].”
BackgroundSkin Tissue Substitutes and Biomaterial Risk Assessment and Testing
Savoji, H., Godau, B., Hassani, M. S., & Akbari, M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00086 · Cited by 150
“In another study, a simpler model containing bi-layer of keratinocytes-fibroblasts and endothelial cells-fibroblasts between three microfluidic channels was proposed to investigate penetration in skin (Wufuer et al., 2016).”
Microfluidic Skin‐on‐a‐Chip Models: Toward Biomimetic Artificial Skin
Sutterby, E., Thurgood, P., Baratchi, S., Khoshmanesh, K., & Pirogova, E. (2020) · Small · doi:10.1002/smll.202002515 · Cited by 140
Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X. (2020) · Micromachines · doi:10.3390/mi11040381 · Cited by 140
“In addition to the organs mentioned above, microfluidic chip models of skin [135], vasculature [136], and tumors [137] are also widely used in drug discovery and preclinical”
BackgroundIn vitro and ex vivo systems at the forefront of infection modeling and drug discovery
Shi, D., Mi, G., Wang, M., & Webster, T. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.030 · Cited by 157
“(D) BBB-ona-chip device with various brain tissue cell co-cultures [161, 162] .”
InfluentialSkin-on-a-chip models: General overview and future perspectives
Risueño, I., Valencia, L., Jorcano, J. L., & Velasco, D. (2021) · APL Bioengineering · doi:10.1063/5.0046376 · Cited by 137
Organ‐on‐a‐Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine
Rodrigues, R. O., Sousa, P. C., Gaspar, J., Bañobre‐López, M., Lima, R. A., & Minas, G. M. H. (2020) · Small · doi:10.1002/smll.202003517 · Cited by 144
Design and Fabrication of Organ-on-Chips: Promises and Challenges
Tajeddin, A., & Mustafaoğlu, N. (2021) · Micromachines · doi:10.3390/mi12121443 · Cited by 158
Emerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 127
Xu, J., Zheng, S., Hu, X., Li, L., Li, W., Parungao, R., Wang, Y., Nie, Y., Liu, T., & Song, K. (2020) · Polymers · doi:10.3390/polym12061237 · Cited by 124
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
“More recent models pattern keratinocytes, fibroblasts, and/or ECs to mimic native organ architecture [180,195,196] and may incorporate hair follicles, adipocytes, mechanical strain, or fluidic connections to other organs [179,180].”
Backgroundvan den Broek, L. J., Bergers, L. I. J. C., Reijnders, C. M. A., & Gibbs, S. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9737-1 · Cited by 115
“Skin-on-chip (cell line) HaCaT KC CL HS27 FB CL HUVEC Multi monolayer skin inflammation /edema model +: mimics KC-Fb interaction Fb-EC interaction +: simple model for paracrine signaling -: non-organotypic [33]”
Kang, K., Ye, S., Jeong, C., Jeong, J., Ye, Y., Jeong, J. Y., Kim, Y.-J., Lim, S., Kim, T. H., Kim, K. Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44064-7 · Cited by 142
“Surgical interventions 2 – 4 (e.g., skin graft) or pharmacological treatments 5,6 are often employed to restore the skin or promote skin regeneration, whereas natural healing of severe scarring requires time and can be fatal because of infections in the worst case.”
Journey of organ on a chip technology and its role in future healthcare scenario
Singh, D., Mathur, A. K., Arora, S., Roy, S., & Mahindroo, N. (2022) · Applied Surface Science Advances · doi:10.1016/j.apsadv.2022.100246 · Cited by 132
Microfluidic Tissue Engineering and Bio‐Actuation
Filippi, M., Buchner, T., Yaşa, Ö., Weirich, S., & Katzschmann, R. K. (2022) · Advanced Materials · doi:10.1002/adma.202108427 · Cited by 133
Dabbagh, S. R., Sarabi, M. R., Birtek, M. T., Mustafaoğlu, N., Zhang, Y. S., & Taşoğlu, S. (2022) · Aggregate · doi:10.1002/agt2.197 · Cited by 119
de Barros, N. R., Kim, H., Gouidie, M. J., Lee, K., Bandaru, P., Banton, E. A., Sarikhani, E., Sun, W., Zhang, S., Cho, H., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/aba503 · Cited by 112
“HUVECs are the most commonly used type of endothelial cells [6, 20, 44].”
InfluentialBreakthroughs and Applications of Organ-on-a-Chip Technology
Koyilot, M. C., Natarajan, P., Hunt, C. R., Sivarajkumar, S., Roy, R., Joglekar, S. S., Pandita, S., Tong, C. W.-C., Marakkar, S., Subramanian, L., et al. (2022) · Cells · doi:10.3390/cells11111828 · Cited by 117
Microneedle Arrays for Sampling and Sensing Skin Interstitial Fluid
Kashaninejad, N., Munaz, A., Moghadas, H., Yadav, S., Umer, M., & Nguyen, N. (2021) · Chemosensors · doi:10.3390/chemosensors9040083 · Cited by 116
“A report from the Human Society International suggests that less than 10% of the conducted research from animal studies is effective and safe in clinical trials in humans [184].”
BackgroundThe emergence of 3D bioprinting in organ-on-chip systems
Fetah, K., Tebon, P., Goudie, M. J., Eichenbaum, J., Ren, L., Barros, N., Nasiri, R., Ahadian, S., Ashammakhi, N., Dokmeci, M. R., et al. (2019) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ab23df · Cited by 98
“Wufuer et al [68] Microfluidic device with 3 layers for co-culture of epithelial, dermal, and endothelial components Application of tumor necrosis factor alpha (TNF-α) induced inflammation and edema, showing application for testing toxicity of cosmetics and drugs”
BackgroundMicrofluidic skin chip with vasculature for recapitulating the immune response of the skin tissue
Kwak, B. S., Jin, S., Kim, S. J., Kim, E. J., Chung, J. H., & Sung, J. H. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27320 · Cited by 97
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Duzagac, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13040737 · Cited by 96
Organs-on-a-chip: a union of tissue engineering and microfabrication
Zhao, Y., Wang, E. Y., Lai, F. B. L., Cheung, K., & Radisic, M. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.12.018 · Cited by 93
Microfluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Self-citationEngineered Skin Tissue Equivalents for Product Evaluation and Therapeutic Applications
Suhail, S., Sardashti, N., Jaiswal, D., Rudraiah, S., Misra, M., & Kumbar, S. G. (2019) · Biotechnology Journal · doi:10.1002/biot.201900022 · Cited by 91
Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption
Allwardt, V., Ainscough, A. J., Viswanathan, P., Sherrod, S. D., McLean, J. A., Haddrick, M., & Pensabene, V. (2020) · Bioengineering · doi:10.3390/bioengineering7030112 · Cited by 88
“Common skin ailments involve inflammation, which has been simulated in a 3-layer microfluidic device using tumor necrosis factor-alpha (TNFα) and treated using dexamethasone [11].”
Method3D organ models—Revolution in pharmacological research?
Weinhart, M., Hocke, A. C., Hippenstiel, S., Kurreck, J., & Hedtrich, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.002 · Cited by 97
“So far, only a handful of studies have performed drug testing in skin models, and of these, only 1-2 drugs were included [56] [57] [58] [59] [60] , the experimental settings varied significantly between them, and the choices of readout parameters have not been sufficiently justified.”
Engineering and monitoring cellular barrier models
Yeste, J., Illa, X., Álvarez, M., & Villa, R. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0108-5 · Cited by 100
“They developed a ‘skin-on-a-chip‘model that mimics the cell layer physiology of the human skin consisting of epidermal, dermal, and endothelial layers [111].”
BackgroundSimulating Inflammation in a Wound Microenvironment Using a Dermal Wound‐on‐a‐Chip Model
Biglari, S., Le, T. Y. L., Tan, R. P., Wise, S. G., Zambon, A., Codolo, G., de Bernard, M., Warkiani, M. E., Schindeler, A., Naficy, S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801307 · Cited by 96
Mimicking Epithelial Tissues in Three-Dimensional Cell Culture Models
Torras, N., García-Díaz, M., Fernández‐Majada, V., & Martínez, E. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00197 · Cited by 98
“Innovative perfusable vascularized skinon-a-chip models (Wufuer et al., 2016; Mori et al., 2017) or immune-competent models (Ramadan and Ting, 2016) have been proposed, both aiming to create more physiologically relevant skin equivalents for drug screening and diseasemodeling”
BackgroundLim, J., Ching, H., Yoon, J., Jeon, N. L., & Kim, Y. (2021) · Nano Convergence · doi:10.1186/s40580-021-00261-y · Cited by 91
Varone, A., Nguyen, J. K., Leng, L., Barrile, R., Sliz, J. D., Lucchesi, C., Wen, N., Gravanis, A., Hamilton, G. A., Karalis, K., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120957 · Cited by 94
In Vitro Models Mimicking Immune Response in the Skin
Moon, S., Kim, D. H., & Shin, J. U. (2021) · Yonsei Medical Journal · doi:10.3349/ymj.2021.62.11.969 · Cited by 77
Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform
Sun, S., Jin, L., Zheng, Y., & Zhu, J. (2022) · Nature Communications · doi:10.1038/s41467-022-33114-1 · Cited by 78
Immune Organs and Immune Cells on a Chip: An Overview of Biomedical Applications
Morsink, M., Willemen, N., Leijten, J., Bansal, R., & Shin, S. (2020) · Micromachines · doi:10.3390/mi11090849 · Cited by 73
“[81] established a skin-on-a-chip with inflammation based on exposure to TNF-α, which corresponded to pathological skin inflammation.”
BackgroundKim, J. J., Ellett, F., Thomas, C. N., Jalali, F., Anderson, R. R., Irimia, D., & Raff, A. B. (2019) · Lab on a Chip · doi:10.1039/c9lc00399a · Cited by 69
Inflammation-on-a-Chip: Probing the Immune System Ex Vivo
Irimia, D., & Wang, X. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.03.011 · Cited by 70
“Skin-on-a-chip devices, which reconstituted the key layers of cells of the skin, have been used to probe the role of soluble inflammation mediators in skin inflammation [46][47].”
BackgroundMicrofluidics-based skin irritation test using in vitro 3D angiogenesis platform
Jusoh, N., Ko, J., & Jeon, N. L. (2019) · APL Bioengineering · doi:10.1063/1.5093975 · Cited by 70
Construction of a high fidelity epidermis-on-a-chip for scalable in vitro irritation evaluation
Zhang, J., Chen, Z., Zhang, Y., Wang, X., Ouyang, J., Zhu, J., Yan, Y., Sun, X., Wang, F., Li, X., et al. (2021) · Lab on a Chip · doi:10.1039/d1lc00099c · Cited by 68
Kumar, V., & Varghese, S. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801198 · Cited by 68
Alternative in vitro models used in the main safety tests of cosmetic products and new challenges
Filaire, E., Nachat, R., Camille, L., Harmand, M., Simon, M., & Poinsot, C. (2022) · International Journal of Cosmetic Science · doi:10.1111/ics.12803 · Cited by 67
Li, M., Sun, L., Liu, Z., Shen, Z., Cao, Y., Han, L., Sang, S., & Wang, J. (2023) · Biomaterials Science · doi:10.1039/d2bm02092k · Cited by 75
In vitro skin three-dimensional models and their applications
Klicks, J., von Molitor, E., Ertongur-Fauth, T., Rudolf, R., & Hafner, M. (2017) · Journal of Cellular Biotechnology · doi:10.3233/jcb-179004 · Cited by 66
In Vitro Immune Organs-on-Chip for Drug Development: A Review
Shanti, A., Teo, J., & Stefanini, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040278 · Cited by 65
“To achieve more physiological relevance, several studies have also incorporated vascularization into their skin-on-chip models utilizing primarily endothelial cells [39,51,52].”
BackgroundAhn, J., Ohk, K., Won, J., Choi, D.-H., Jung, Y. H., Yang, J. H., Jun, Y., Kim, J.-A., Chung, S., & Lee, S.-H. (2023) · Nature Communications · doi:10.1038/s41467-023-37187-4 · Cited by 65
Self-citationSkin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
Zoio, P., & Oliva, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030682 · Cited by 76
“proposed a model consisting of three layers (epidermal, dermal and vascular) co-cultured inside a SoC device [110].”
BackgroundTargeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
Quílez, C., Bebiano, L. B., Jones, E., Maver, U., Meesters, L., Parzymies, P., Petiot, E., Rikken, G., Risueño, I., Zaidi, H., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.032 · Cited by 65
Staicu, C. E., Jipa, F., Axente, E., Radu, M., Radu, B. M., & Sima, F. (2021) · Biomolecules · doi:10.3390/biom11060916 · Cited by 68
Current advances in skin-on-a-chip models for drug testing
Zhang, Q., Sito, L., Mao, M., He, J., Zhang, Y. S., & Zhao, X. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.08.01 · Cited by 63
“designed an in vitro human sk in-on-a-ch ip dev i ce compr i s ing three polydimethylsiloxane (PDMS) layers and two porous membranes to enable direct co-culture of keratinocytes (epidermal layer), fibroblasts (dermal layer) and vein endothelial cells (endothelial layer) in a microfluidic system (34).”
BackgroundInvestigations on T cell transmigration in a human skin-on-chip (SoC) model
Ren, X., Getschman, A. E., Hwang, S. T., Volkman, B. F., Klonisch, T. C., Levin, D. B., Zhao, M., Santos, S. C., Liu, S., Cheng, J., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01194k · Cited by 67
Engineered Vasculature for Organ-on-a-Chip Systems
Aazmi, A., Zhou, H., Li, Y., Yu, M., Xu, X., Wu, Y., Ma, L., Zhang, B., & Yang, H. (2021) · Engineering · doi:10.1016/j.eng.2021.06.020 · Cited by 69
Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review
Nitsche, K. S., Müller, I. I., Malcomber, S., Carmichael, P. L., & Bouwmeester, H. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03234-0 · Cited by 80
Advances in TEER measurements of biological barriers in microphysiological systems
Nazari, H., Shrestha, J., Naei, V. Y., Bazaz, S. R., Sabbagh, M., Thiery, J. P., & Warkiani, M. E. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115355 · Cited by 72
Stem cells, niches and scaffolds: Applications to burns and wound care
Watt, S. M., & Pleat, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.012 · Cited by 66
Artificial skin models for animal-free testing
Yun, Y. E., Jung, Y. J., Choi, Y. J., Choi, J. S., & Cho, Y. W. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0389-1 · Cited by 67
Use of stem cells as alternative methods to animal experimentation in predictive toxicology
Kim, T., Che, J., & Yun, J.-W. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.03.016 · Cited by 63
3D Immunocompetent Organ‐on‐a‐Chip Models
Maharjan, S., Cecen, B., & Zhang, Y. S. (2020) · Small Methods · doi:10.1002/smtd.202000235 · Cited by 62
Prasad, M., Kumar, R., Buragohain, L., Kumari, A., & Ghosh, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696668 · Cited by 63
Microfluidic platforms for modeling biological barriers in the circulatory system
Yu, F., Kumar, N. D. O. S., Choudhury, D., Foo, L. C., & Ng, S. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.036 · Cited by 61
A perfusable vascularized full-thickness skin model for potential topical and systemic applications
Salameh, S., Tissot, N., Cache, K., Lima, J., Suzuki, I., Marinho, P. A., Rielland, M., Sœur, J., Takeuchi, S., Germain, S., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abfca8 · Cited by 67
“Besides topical applications, having a perfusable vascularized skin model holds many interests for systemic exposure either for inflammation studies [70] or drug screening and toxicity assessment [58, 71].”
BackgroundRivera, K. R., Yokus, M. A., Erb, P. D., Pozdin, V. A., & Daniele, M. (2019) · The Analyst · doi:10.1039/c8an02201a · Cited by 57
Choi, K.-Y. G., Wu, B. C., Lee, A. H., Baquir, B., & Hancock, R. E. W. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00228 · Cited by 59
“…technology helps to fill this gap since the skin is constructed in the presence of fluid flow under controlled microenvironments that closely mimics the mechanical force and biochemical gradients encountered by natural human skin (O’Neill et al., 2008; Wufuer et al., 2016; Lee et al., 2017).”
BackgroundDevelopment of Skin-On-A-Chip Platforms for Different Utilizations: Factors to Be Considered
Ponmozhi, J., Dhinakaran, S., Varga‐Medveczky, Z., Fónagy, K., Bors, L. A., Iván, K., & Erdő, F. (2021) · Micromachines · doi:10.3390/mi12030294 · Cited by 57
“, dexamethasone) on reducing tumor necrosis factor‐alpha (TNF‐α)‐induced inflammation and edema [71].”
BackgroundMethodInfluentialEngineered Biomimetic Membranes for Organ-on-a-Chip
Rahimnejad, M., Rasouli, F., Jahangiri, S., Ahmadi, S., Rabiee, N., Farani, M. R., Akhavan, O., Asadnia, M., Fatahi, Y., Hong, S., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00531 · Cited by 59
Decellularized extracellular matrix bioinks and their application in skin tissue engineering
Khoshnood, N., & Zamanian, A. (2020) · Bioprinting · doi:10.1016/j.bprint.2020.e00095 · Cited by 53
Comprehensive Development in Organ-On-A-Chip Technology
Joseph, X., Akhil, V., Arathi, A., & Mohanan, P. V. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.07.014 · Cited by 61
Innovations in Stem Cell Therapy for Diabetic Wound Healing
Ho, J. O. Y., Yue, D., Cheema, U., Hsia, H. C., & Dardik, A. (2022) · Advances in Wound Care · doi:10.1089/wound.2021.0104 · Cited by 60
“113 Orga-noids that closely resemble human skin may re-capitulate physiological dysregulation as seen in diabetes, similar to other organ-on-a-chip diabetic models.”
Design of an Integrated Microvascularized Human Skin-on-a-Chip Tissue Equivalent Model
Jones, C. F. E., Ciò, S. D., Connelly, J. T., & Gautrot, J. E. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.915702 · Cited by 57
Li, Y., Lin, Z., Wang, Y., Ju, S., Wu, H., Jin, H., Ma, S., & Zhang, B. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104302 · Cited by 56
“All these platforms are simple to operate, allow the evaluation of drug parameters, and are powerful tools for in vitro screening of drugs (Wufuer et al., 2016).”
BackgroundMicrofluidic-based skin-on-chip systems for safety assessment of nanomaterials
Costa, S. D. F. Z., Vilas‐Boas, V., Lebre, F., Granjeiro, J. M., Catarino, C. M., Teixeira, L. M., Loskill, P., Alfaro‐Moreno, E., & Ribeiro, A. R. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.05.009 · Cited by 61
Rothbauer, M., Bachmann, B., Eilenberger, C., Kratz, S. R. A., Spitz, S., Höll, G., & Ertl, P. (2021) · Micromachines · doi:10.3390/mi12050470 · Cited by 55
“PDMS and PET porous membranes Monolayer Skin epidermis, inflamatory, edem Human keratinocytes HaCaT, fibroblasts, Human umbilical vein endothelial cells (HUVECs) Response to TNF-a (mRNA expression levels ELISA), Tight junction staining, leakage assay Multi barrier competent Chip (3) TNF-α-induced inflammation treatmen…”
MethodLagoa, R., Marques‐da‐Silva, D., Diniz, M., Daglia, M., & Bishayee, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.002 · Cited by 57
Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip
Jeon, H. M., Kim, K., Choi, K. C., & Sung, G. Y. (2020) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2019.09.044 · Cited by 50
A human-on-a-chip approach to tackling rare diseases
de Mello, C. P. P., Rumsey, J. W., Slaughter, V. L., & Hickman, J. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.001 · Cited by 53
Zoio, P., Lopes-Ventura, S., & Oliva, A. (2021) · Micromachines · doi:10.3390/mi12070816 · Cited by 48
Human Organs‐on‐Chips: A Review of the State‐of‐the‐Art, Current Prospects, and Future Challenges
Zarrintaj, P., Saeb, M. R., Stadler, F. J., Yazdi, M. K., Nasirinezhad, M., Mohebbi, S., Seidi, F., Ganjali, M. R., & Mozafari, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000526 · Cited by 56
Riddle, R. B., Jennbacken, K., Hansson, K. M., & Harper, M. T. (2022) · Scientific Reports · doi:10.1038/s41598-022-10849-x · Cited by 58
Kumar, D., Nadda, R., & Repaka, R. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03062-7 · Cited by 64
“Wufuer et al. [110] created a skin-on-chip device supplied with blood to replicate edema, medication therapy, and inflammation.”
In Vitro Models for Studying Transport Across Epithelial Tissue Barriers
Arumugasaamy, N., Navarro, J., Leach, J. K., Kim, P. C. W., & Fisher, J. P. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-02124-w · Cited by 53
Non-animal models in dermatological research
Dellambra, E. (2018) · ALTEX · doi:10.14573/altex.1808022 · Cited by 48
Viable cell culture in PDMS-based microfluidic devices
Tanyeri, M., & Tay, S. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.09.007 · Cited by 62
“…et al., 2014), female reproductive tract (Xiao et al., 2017), nerve (Majumdar et al., 2011; Shi et al., 2013), muscle (Grosberg et al., 2012), skin (Wufuer et al., 2016), blood-brain barrier (Booth &Kim, 2012; Griep et al., 2013), retina (Dodson et al., 2015), and artery (Yasotharan et al., 2015).”
Background
Metadata
- Authors
- Wufuer, M., Lee, G., Hur, W., Jeon, B., Kim, B. J., Choi, T. H., & Lee, S.
- Affiliations
- Seoul National University (KR)
- Korea University (KR)
- Corresponding author
- Choi, Tae Hyun
- Venue
- Scientific Reports
- Published
- 2016-11-21
- Volume
- 6
- Issue
- 1
- Pages
- 37471-37471
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5116589
- OpenAlex
- W2550854745
- Cited by
- 356
- References
- 54
- Citations by year
- 2026: 39 · 2025: 32 · 2024: 40 · 2023: 36 · 2022: 50 · 2021: 52 · 2020: 35 · 2019: 24 · 2018: 36 · 2017: 12
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Food and Drug Safety (16182MFDS526)
- Korea Institute of Science and Technology
- Korea Research Institute of Bioscience and Biotechnology (KGM4891511)
- Ministry of Public Safety and Security (MPSS-CG-2016-02)
- KU-KIST Graduate School of Converging Science and Technology
- Korean National Police Agency ((PA‐H000001))
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- skin-on-a-chip, in vitro skin model, microfluidic co-culture, skin inflammation, edema, TNF-α, inflammatory cytokines, skin barrier function, tight junctions, endothelial permeability, drug toxicity testing
- MeSH terms
- Dexamethasone, Edema, Humans, Immunohistochemistry, Inflammation, Models, Biological, Skin, Tumor Necrosis Factor-alpha, Tight Junctions, Protective Agents, Lab-On-A-Chip Devices, Human Umbilical Vein Endothelial Cells, Optical Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.